Published in Stem Cell Rev on January 30, 2009
Repair of the injured adult heart involves new myocytes potentially derived from resident cardiac stem cells. Circ Res (2011) 2.02
Challenges for heart disease stem cell therapy. Vasc Health Risk Manag (2012) 1.02
Improved functional activity of bone marrow derived circulating progenitor cells after intra coronary freshly isolated bone marrow cells transplantation in patients with ischemic heart disease. Stem Cell Rev (2011) 0.89
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell (2006) 120.51
Generation of germline-competent induced pluripotent stem cells. Nature (2007) 32.77
In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature (2007) 28.24
Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A (1981) 18.96
Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol (2007) 14.48
Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med (2006) 11.66
Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature (2005) 9.44
Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet (2004) 9.35
Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature (2004) 8.87
Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature (2004) 8.36
Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci U S A (2003) 7.87
Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet (2006) 7.33
Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med (2006) 7.28
Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet (2003) 6.85
Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med (2006) 6.77
Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med (2007) 6.68
Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest (2001) 6.59
Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation (2002) 6.50
Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol Med (2000) 5.83
Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol (2004) 5.82
Stem-cell therapy for cardiac disease. Nature (2008) 5.75
Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation (2003) 5.34
Generation of induced pluripotent stem cells in the absence of drug selection. Cell Stem Cell (2007) 4.94
MicroRNA regulation of cell lineages in mouse and human embryonic stem cells. Cell Stem Cell (2008) 4.70
Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol (2004) 4.50
Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. J Cell Mol Med (2004) 4.16
Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts. J Clin Invest (1996) 3.87
Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve (1995) 3.84
Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance. Am J Physiol Heart Circ Physiol (2006) 3.78
Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ Res (2002) 3.69
Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann Thorac Surg (2002) 3.62
The promise of human induced pluripotent stem cells for research and therapy. Nat Rev Mol Cell Biol (2008) 3.56
Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases. JAMA (2008) 3.23
Autologous transplantation of bone marrow cells improves damaged heart function. Circulation (1999) 3.17
Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation (2008) 3.11
Generation of functional murine cardiac myocytes from induced pluripotent stem cells. Circulation (2008) 3.11
Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation (2005) 3.10
SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction. FASEB J (2007) 3.01
Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial. Circulation (2007) 2.88
Bone marrow stem cells contribute to repair of the ischemically injured renal tubule. J Clin Invest (2003) 2.81
Formation of human myocardium in the rat heart from human embryonic stem cells. Am J Pathol (2005) 2.60
Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet (2003) 2.59
MesP1 drives vertebrate cardiovascular differentiation through Dkk-1-mediated blockade of Wnt-signalling. Nat Cell Biol (2008) 2.55
Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: a preclinical study. Lancet (2005) 2.36
Bone marrow mesenchymal stem cells differentiate into functional cardiac phenotypes by cardiac microenvironment. J Mol Cell Cardiol (2006) 2.33
Cell-based therapy of myocardial infarction. Arterioscler Thromb Vasc Biol (2007) 2.31
Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts. Proc Natl Acad Sci U S A (2008) 2.25
Restoration of cardiac progenitor cells after myocardial infarction by self-proliferation and selective homing of bone marrow-derived stem cells. Circ Res (2005) 2.18
Identification and selection of cardiomyocytes during human embryonic stem cell differentiation. FASEB J (2007) 2.10
Enhanced cardiogenesis in embryonic stem cells overexpressing the GATA-4 transcription factor. Development (1997) 2.07
Cardiopoietic programming of embryonic stem cells for tumor-free heart repair. J Exp Med (2007) 1.97
Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction. J Am Coll Cardiol (2008) 1.86
Monocyte chemotactic protein-3 is a myocardial mesenchymal stem cell homing factor. Stem Cells (2006) 1.84
Xenografted adult human mesenchymal stem cells provide a platform for sustained biological pacemaker function in canine heart. Circulation (2007) 1.76
Stable benefit of embryonic stem cell therapy in myocardial infarction. Am J Physiol Heart Circ Physiol (2004) 1.73
Regeneration of infarcted myocardium by intramyocardial implantation of ex vivo transforming growth factor-beta-preprogrammed bone marrow stem cells. Circulation (2005) 1.70
Myocyte and myogenic stem cell transplantation in the heart. Cardiovasc Res (2003) 1.66
Retinoic acid accelerates embryonic stem cell-derived cardiac differentiation and enhances development of ventricular cardiomyocytes. J Mol Cell Cardiol (1997) 1.60
Effect of cell-based intercellular delivery of transcription factor GATA4 on ischemic cardiomyopathy. Circ Res (2007) 1.59
HAEMATOPOIETIC CHIMERA IN MAN AFTER ALLOGENIC (HOMOLOGOUS) BONE-MARROW TRANSPLANTATION. (CONTROL OF THE SECONDARY SYNDROME. SPECIFIC TOLERANCE DUE TO THE CHIMERISM). Br Med J (1963) 1.59
Selection of ventricular-like cardiomyocytes from ES cells in vitro. FASEB J (2000) 1.56
Adult mesenchymal stem cells: a pluripotent population with multiple applications. Curr Stem Cell Res Ther (2006) 1.51
Genetic enhancement of stem cell engraftment, survival, and efficacy. Circ Res (2008) 1.42
Vascular endothelial growth factor receptor upregulation in response to cell-based angiogenic gene therapy. Ann Thorac Surg (2005) 1.38
Stable fetal cardiomyocyte grafts in the hearts of dystrophic mice and dogs. J Clin Invest (1995) 1.36
Hyaluronan mixed esters of butyric and retinoic Acid drive cardiac and endothelial fate in term placenta human mesenchymal stem cells and enhance cardiac repair in infarcted rat hearts. J Biol Chem (2007) 1.35
Insulin-like growth factor promotes engraftment, differentiation, and functional improvement after transfer of embryonic stem cells for myocardial restoration. Stem Cells (2004) 1.35
Transplantation of adipose derived stromal cells is associated with functional improvement in a rat model of chronic myocardial infarction. Eur J Heart Fail (2008) 1.29
Differentiation in vivo of cardiac committed human embryonic stem cells in postmyocardial infarcted rats. Stem Cells (2007) 1.24
Isolation and characterization of bone marrow-derived mesenchymal progenitor cells with myogenic and neuronal properties. Exp Cell Res (2007) 1.20
Stem cell therapy enhances electrical viability in myocardial infarction. J Mol Cell Cardiol (2006) 1.19
Bone marrow-derived regenerated cardiomyocytes (CMG Cells) express functional adrenergic and muscarinic receptors. Circulation (2002) 1.19
Three-, 6-, and 12-month results of autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction. Int J Cardiol (2007) 1.17
Cardioinductive network guiding stem cell differentiation revealed by proteomic cartography of tumor necrosis factor alpha-primed endodermal secretome. Stem Cells (2007) 1.16
CD117+ stem cells play a key role in therapeutic angiogenesis induced by bone marrow cell implantation. Am J Physiol Heart Circ Physiol (2003) 1.16
SDF-1 recruits cardiac stem cell-like cells that depolarize in vivo. Cell Transplant (2007) 1.16
Intramyocardial injection of allogenic bone marrow-derived mesenchymal stem cells without immunosuppression preserves cardiac function in a porcine model of myocardial infarction. J Cardiovasc Pharmacol Ther (2005) 1.15
Long-term survival of AT-1 cardiomyocyte grafts in syngeneic myocardium. Am J Physiol (1993) 1.14
Pretreatment of adult bone marrow mesenchymal stem cells with cardiomyogenic growth factors and repair of the chronically infarcted myocardium. Am J Physiol Heart Circ Physiol (2006) 1.13
Genomic chart guiding embryonic stem cell cardiopoiesis. Genome Biol (2008) 1.13
Adult stem cells and their trans-differentiation potential--perspectives and therapeutic applications. J Mol Med (Berl) (2008) 1.12
Myocyte enhancer factor 2C and Nkx2-5 up-regulate each other's expression and initiate cardiomyogenesis in P19 cells. J Biol Chem (1998) 1.12
Natural history of fetal rat cardiomyocytes transplanted into adult rat myocardial scar tissue. Circulation (1997) 1.10
The bone marrow--cardiac axis of myocardial regeneration. Prog Cardiovasc Dis (2007) 1.10
Human umbilical cord blood-derived CD133+ cells enhance function and repair of the infarcted myocardium. Stem Cells (2005) 1.08
Cardiomyocyte-mediated contact programs human mesenchymal stem cells to express cardiogenic phenotype. J Thorac Cardiovasc Surg (2003) 1.08
Direct delivery of syngeneic and allogeneic large-scale expanded multipotent adult progenitor cells improves cardiac function after myocardial infarct. Cytotherapy (2007) 1.07
Stimulation of paracrine pathways with growth factors enhances embryonic stem cell engraftment and host-specific differentiation in the heart after ischemic myocardial injury. Circulation (2005) 1.07
Transforming growth factor-beta2 enhances differentiation of cardiac myocytes from embryonic stem cells. Biochem Biophys Res Commun (2005) 1.07
Overexpression of TNNI3K, a cardiac-specific MAP kinase, promotes P19CL6-derived cardiac myogenesis and prevents myocardial infarction-induced injury. Am J Physiol Heart Circ Physiol (2008) 1.05
Role of adult bone marrow stem cells in the repair of ischemic myocardium: current state of the art. Exp Hematol (2008) 1.05
Mechanical and electrical effects of cell-based gene therapy for ischemic cardiomyopathy are independent. Hum Gene Ther (2006) 1.04
Mesenchymal stem cells for the treatment of heart failure. Int J Hematol (2007) 1.02
VEGF enhances functional improvement of postinfarcted hearts by transplantation of ESC-differentiated cells. J Appl Physiol (1985) (2002) 0.99
Optical mapping of late myocardial infarction in rats. Am J Physiol Heart Circ Physiol (2005) 0.96
Multipotent adult progenitor cell transplantation increases vascularity and improves left ventricular function after myocardial infarction. J Tissue Eng Regen Med (2007) 0.96
Stemming heart failure with cardiac- or reprogrammed-stem cells. J Cell Mol Med (2008) 0.96
Allopurinol/uricase and ibuprofen enhance engraftment of cardiomyocyte-enriched human embryonic stem cells and improve cardiac function following myocardial injury. Eur J Cardiothorac Surg (2005) 0.95
Use of adult marrow mesenchymal stem cells for regeneration of cardiomyocytes. Bone Marrow Transplant (2003) 0.95
Monocyte chemotactic protein-3 is a myocardial mesenchymal stem cell homing factor. Stem Cells (2006) 1.84
Myocardial CXCR4 expression is required for mesenchymal stem cell mediated repair following acute myocardial infarction. Circulation (2012) 1.52
Chronobiological patterns of acute aortic dissection. Circulation (2002) 1.43
Disruption of protein kinase A interaction with A-kinase-anchoring proteins in the heart in vivo: effects on cardiac contractility, protein kinase A phosphorylation, and troponin I proteolysis. J Biol Chem (2008) 1.29
Depression and heart disease: what do we know, and where are we headed? Cleve Clin J Med (2009) 1.12
Significance of thymosin β4 and implication of PINCH-1-ILK-α-parvin (PIP) complex in human dilated cardiomyopathy. PLoS One (2011) 1.09
Cytokine expression after vaginal distention of different durations in virgin Sprague-Dawley rats. J Urol (2008) 1.02
Tumor necrosis factor alpha (TNF-alpha) receptor-II is required for TNF-alpha-induced leukocyte-endothelial interaction in vivo. Blood (2006) 1.01
Pelvic organ distribution of mesenchymal stem cells injected intravenously after simulated childbirth injury in female rats. Obstet Gynecol Int (2011) 1.00
Continuous delivery of stromal cell-derived factor-1 from alginate scaffolds accelerates wound healing. Cell Transplant (2009) 1.00
Differences in clinical presentation, management, and outcomes of acute type a aortic dissection in patients with and without previous cardiac surgery. Circulation (2004) 0.93
Magic-factor 1, a partial agonist of Met, induces muscle hypertrophy by protecting myogenic progenitors from apoptosis. PLoS One (2008) 0.90
Development of a peptide-targeted, myocardial ischemia-homing, mesenchymal stem cell. J Drug Target (2011) 0.87
Chemokine upregulation in response to anal sphincter and pudendal nerve injury: potential signals for stem cell homing. Int J Colorectal Dis (2011) 0.87
Mesenchymal stem cells can improve anal pressures after anal sphincter injury. Stem Cell Res (2012) 0.81
Detection and quantification of fluorescent cell clusters in cryo-imaging. Int J Biomed Imaging (2012) 0.80
Cardiovascular repair and regeneration 2008: the fourth International Conference on Cell Therapy for Cardiovascular Disease (IC3D). EuroIntervention (2008) 0.77
Low current electrical stimulation upregulates cytokine expression in the anal sphincter. Int J Colorectal Dis (2011) 0.76
Images in cardiovascular medicine. Left anterior descending coronary artery occlusion secondary to blunt chest trauma. Circulation (2009) 0.75
Stromal Cell-Derived Factor 1 Plasmid Regenerates Both Smooth and Skeletal Muscle After Anal Sphincter Injury in the Long Term. Dis Colon Rectum (2017) 0.75
The future--panel discussion. J Invasive Cardiol (2004) 0.75
Regenerating the Anal Sphincter: Cytokines, Stem Cells, or Both? Dis Colon Rectum (2017) 0.75